LifeScan
Medical equipment company
From Wikipedia, the free encyclopedia
LifeScan Enterprises LLC. is a diagnostic systems manufacturer with products focusing on the diabetes market, specifically blood glucose monitoring systems. Corporate headquarters in Malvern, Pennsylvania.
| Industry | Medical devices |
|---|---|
| Founded | 1981 |
| Headquarters | |
Area served | Global |
| Revenue | US$1.5 billion (2017)[1] |
Number of employees | 2,400(2020)[2] |
| Parent | Platinum Equity |
History
LifeScan was established in 1981.[3] It was acquired by Johnson & Johnson (J&J) in 1986,[2][4] and in June 2018, J&J agreed to sell LifeScan to Platinum Equity as part of its strategic exit from the diabetes device market, accepting an offer originally tendered in March 2018.[1] The divestiture completed in October 2018.[1][5]
LifeScan manufactures and markets the OneTouch Ultra and OneTouch Verio families of products for home use.[1] The company philosophy is to "create a world without limits for people with diabetes." During its existence, LifeScan revolutionized blood glucose monitoring by introduction of its "One Touch" systems. Originally, the measurement was made using a test strip which changed color depending on the glucose content of a blood sample, and LifeScan rose to become the world-leading producer of such systems in the early 1990s. Later, the measurement technology was changed to electrochemistry, but LifeScan maintained a leading position in the industry.
LifeScan has facilities in Inverness, Scotland; and Cabo Rojo, Puerto Rico. Animas Corporation of West Chester, Pennsylvania, which produced insulin pumps for people with diabetes, was acquired by Johnson & Johnson in 2006 and now closed, reported to LifeScan.
LifeScan, which employed 2400 people as of early 2018, was the central part of J&J's diabetes device business.[2] J&J announced plans to exit from the diabetes device market in 2017, including divesting LifeScan.[2] In January 2018, there were reports of Chinese investors expressing interest in purchasing the company for US$3 to 4 billion, while in March, Platinum Equity offered the far smaller sum of US$2.1 billion for the unit.[2][6]
On July 15, 2025, LifeScan filed for Chapter 11 bankruptcy protection as part of a plan to be taken over by its creditors. The company listed assets and liabilities between $1 billion and $10 billion.[7] LifeScan Enterprises LLC. emerged from bankruptcy on December 8, 2025, now operating under LifeScan Enterprises LLC. formerly LifeScan, Inc.[8]
